Immunogenicity and Efficacy of High-dose Trivalent Inactivated Seasonal Influenza Vaccine(Fluzone High Dose) in Immunocompromised Children and Young Adults.
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Oct 2017 Status changed from active, no longer recruiting to completed.
- 04 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Jun 2017.